Sample | Title | Value | Rank |
GSM16943 | Wild Type Control Set A | 2104.7 | 98 |
GSM18491 | WT Control Sample B | 2067.5 | 98 |
GSM18492 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A | 1890.3 | 97 |
GSM18493 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B | 1911.7 | 98 |
GSM18494 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A | 2068.5 | 98 |
GSM18495 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B | 2297.1 | 98 |
GSM18496 | MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A | 2027.1 | 98 |
GSM18497 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B | 2276.8 | 98 |
GSM18498 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A | 2370.3 | 98 |
GSM18499 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B | 2338.6 | 98 |
GSM18500 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A | 2397.2 | 98 |
GSM18501 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B | 2658 | 99 |